Loading

Annals of Clinical and Medical Microbiology

Antibiotics Resistant Profile of Multi Drug Resistance Uropathogenic Escherichia coli in Southeastern Nigeria

Research Article | Open Access | Volume 3 | Issue 2

  • 1. Department of Medical Microbiology, University of Nigeria Teaching Hospital, Nigeria
+ Show More - Show Less
Corresponding Authors
Nwafia N Ifeyinwa, Department of Medical Microbiology, University of Nigeria Teaching Hospital, Nigeria, Tel: 234-803-6664-432;
Abstract

Objective: To determine the prevalence and antimicrobial resistance pattern of uropathogenic Escherichia coli (E. coli) from patients in a tertiary hospital, in southeastern Nigeria.

Method: This was a cross sectional study carried out at the Medical Microbiology Department of University of Nigeria Teaching Hospital (UNTH) Enugu, in southeastern Nigeria from July 2013 to June 2016. Ethical Clearance was obtained from Health research ethical committee of University of Nigeria Teaching Hospital Enugu. A total of 6553 urine samples were examined and cultured in 5% sheep blood agar and MacConkey agar plate. The plates were incubated aerobically at 37° C for 18 hours. After which E. coli isolates were identified using standard biochemical tests. Antimicrobial resistant testing were done on Muller Hinton plates using modified Kirby-Bauer method and interpreted according to Clinical and Laboratory Standards Institute (CLSI) guidelines. Analytical and descriptive statistics was done using statistical package for the social sciences (SPSS) version.

Result: Out of 6553 urine samples, 2062 showed significant growth with E. coli (65.6%) being the most predominant followed by Klebsiella spp. (19.3%), Proteus spp (6.2%), Pseudomonas aeruginosa (4.7%) and Staphylococcus aureus (3.5%). The age group 30-39 years (27.3%) had the highest prevalence. (χ2 =572.1, p= 0.001). Females constituted 81.4 % of the study (χ2 =469.43, p< 0.000). The antibiotics that showed yearly increase in resistance were ciprofloxacin, augmentin, amoxicillin, cotrimoxazole, nitrofurantoin, ceftriaxone, gentamicin and ofloxacin. All the isolates had a multiple antibiotics resistance (MAR) index greater than 0.2.

Conclusion: E. coli isolates showed multiple drug resistance to commonly used antibiotics in the treatment of urinary tract infections. Antibiotic guidelines and good practice of antibiotic stewardship is of paramount importance for the optimum care of the patient.

Citation

Martin O, Ifeyinwa N, Samuel E, Paul N, Ibuchukwu O, et al. (2018) Antibiotics Resistant Profile of Multi Drug Resistance Uropathogenic Escherichia coli in Southeastern Nigeria Ann Clin Med Microbiol 3(2): 1020.

Keywords

• Antimicrobial; Escherichia coli; Resistance; Urinary 
tract; Uropathogens

ABBREVIATIONS

ATCC: American Type Culture Collection; CLSI: Clinical and Laboratory Standards Institute; E. coli Escherichia coli; MAR: Multiple Antibiotics Resistance Spp: Species; UNTH: University of Nigeria Teaching Hospital

INTRODUCTION

Infection of the urinary tract system is the second commonest site of infections after the respiratory tract system [1-4]. It is estimated that 10% of people will experience it during their lifetime, with women more affected than men [5,6]. E. coli is the commonest bacterium seen, causing 85% of communityacquired and 50% of hospital-acquired UTIs [7]. There are reports of increasing number of isolates resistance to antimicrobials [8-10]. Resistant uropathogenic E. coli in the United States increased from 9% in 2001 to 17% in 2010 [11].Also in Nigeria, a study done in Shika-Zaria showed 95% resistance to routinely used drugs for the treatment of urinary tract infections [12]. The Knowledge of the resistant pattern will help to advice the clinicians on antibiotic guidelines and stewardship to optimize patients care.

MATERIALS AND METHODS

Study design

A cross- sectional study was done covering a period of 3 years (from July 2013 to June 2016) in UNTH Enugu. The biodata namely, gender, age, clinics and wards were obtained from the request forms of the patients sent to the microbiology laboratory for UTI investigations. All the urine samples were routinely examined macroscopically and microscopically, and then cultured with calibrated loop technique delivering 0.002ml on 5% sheep blood and MacConkey agar plates. The plates were incubated aerobically at 35-370 C for 18-24 hours. The suspected colonies of E. coli which showed significant growth (≥ 105 cfu/ ml) were Gram stained and identified with the following tests; motility, indole production, methyl red, Voges Proskeur, triple iron sugar utilization, urea test and citrate utilization tests as described in standard bacteriological methods [13].

Susceptibility testing of confirmed isolates was done by disc diffusion method using modified Kirby-Bauer on Mueller-Hinton agar. The sensitivity was interpreted according to CLSI guideline [14]. E coli (ATCC 25922) was used as control. Data analysis was done using SPSS version [15]. Hence, the results were summarized and presented in tables displaying frequencies and percentages (descriptive statistics). Inferential statistics was conducted using chi square test to determine the association between independent variables and dependent variables. Statistical significance was set at p<0.05. Multiple antibiotics index was also determined.

RESULTS AND DISCUSSIONS

A total of 6553 urine samples (mid stream urine 5786, urine collected from catheter 546 and supra pubic aspirates 221) were sent to the Medical Microbiology Department for urine microscopy, culture and sensitivity. Two thousand and sixty-two (2062) samples yielded significant growth of microbial colonies. Of the 2062 significant growth, 1353(65.6 %) samples yielded E. coli. Klebsiella species 398 (19.3 %), Proteus species 128 (6.2%), Pseudomonas aeruginosa 97 (4.7%), Staphylococcus aureus 72 (3.5 %), Enterococcus species 49 (2.4 %), Candida species 34 (1.7 %) as shown in (Table 1). The age group 30-39 years (27.3 %) had the highest prevalence, with the least being 0-9 years (2.1 %) (Table 2). There was significant difference in the distribution of E. coli among the age groups (χ2 = 572.1, p = 0.001). The sex distribution revealed that 81.4% were females, and this was significant (χ2 = 469.43, p<0.000) as shown in (Table 2). The antibiotics that showed yearly significant increase in resistance to the E. coli isolates were ciprofloxacin, augmentin, amoxicillin, cotrimoxazole, nitrofurantoin, ceftriaxone, gentamicin and ofloxacin (Table 3). All the isolates had multiple antibiotics resistance (MAR) index greater than 0.2 as shown in (Table 4).

Urinary tract infections (UTIs) are among the most commonly encountered infectious diseases affecting people of all age groups worldwide [1]. Multidrug resistant uropathogenic E. coli is causing serious public health problem and is associated with poor patient outcomes, increased length of hospital stay and increased costs. This study provides the prevalence and current antibiotic resistant pattern of uropathogenic E. coli in UNTH Enugu.

In this study, E. coli was found to be the most common cause of urinary tract infections with a rate of 65.6%. The occurrence of E. coli as the most common cause of UTI has been reported in previous studies though with variations in their rates. In Abuja [8], Okada, [16], Ethiopia [17] and India [18], rates of 37%, 41.16%, 63.6% and 38.06% were reported respectively. These variations in the rates of E. coli isolated from different studies may be because of differences in sample size and the populations studied. Also difference in identification methods may also influence the rates reported from different studies. However, Klebsiella spp and Staphylococcus aureus were reported in studies done in Rivers [19]. And Edo states [16]. Respectively as the most predominant pathogen. Bacteria causes of UTI can show geographic variations and may even vary over time within a population [20].

The incidence of UTI was highest among the age groups 30- 39 year old followed by 20-29. This is in keeping with previous studies which demonstrated high prevalence of UTI in ages 20- 39 years [21,22]. However, this is not in agreement with the study done in Cameroon [22], that they reported high prevalence in older age group. The age group reported in this study is the most sexually active group of the population and sexual activities predispose them to UTI. Most women of child-bearing age fall within this group.

Our study showed that the frequency of UTI is greater in females as compared to males [15,23,24]. This finding may be attributed to anatomy of the females urogenital system that has shorter urethra and the close proximity of their urethral opening to the anus [ 18], hence making it easier for enteric normal flora to colonize the urinary system. Also, prostatic fluids are known to have antibacterial properties and this may contribute to lower rate of infection seen in males [25].

The susceptibility pattern of uropathogenic E. coli varies in different geographical locations and empirical treatment by the clinician is based on the knowledge of the local susceptibility patterns. The present study shows increasing resistance of the uropathogenic E. coli to different classes of antimicrobials. All the uropathogenic E. coli were resistant to three or more of the antibiotics tested, with multiple antibiotic resistance indexes greater than 0.2.This suggests that the organisms may have been previously exposed to the different antibiotics used in this study. Multiple antibiotics resistance (MAR) index is a tool that reveals the spread of bacterial resistance in a given population [26]. MAR index of a bacterial species greater than 0.2 signifies that the strain originated from an environment where the antibiotics are used [26,27], so this high rate of resistance to the antibiotics in this study maybe due to the common use of these drugs in treatment of UTI in our environment. Inappropriate exposure to antibiotics is the main driving force of development of drug resistance. This is in agreement with studies done in Abuja [8], Zaria [27], Iran [23] and Pakistan [28]. That also reported resistance of the isolates to commonly used drugs in treating UTIs.

The international guideline for treatment of UTI suggests cotrimoxazole and amoxicillin-clavulanic acid as the drugs of choice for treatment of urinary tract infections [28]. These drugs that were recommended for UTI treatment showed high resistance in this study, so their continual usage will always lead to treatment failure with resultant poor patient outcome. The yearly resistant profile showed imipenem followed by cefotaxime, meropenem and levofloxacin to be least resistant. This may be because these drugs are rarely used in the treatment of uncomplicated UTI so they are less likely to be abused. The resistant rates vary in different countries, regions and institutions over time. This shows the superiority of the knowledge of local resistance patterns for proper management of the patients. Hence, there is need for mandatory urine culture and susceptibility tests for all patients suspected of having UTIs so as to guide for proper treatment. This empirical system should be incorporated in the national and regional antibiotic stewardship policy which should drive the search for new effective antibiotics probiotics, and research in microbiome for future use.

Table 1: Percentage frequency of isolates.

Isolates Total number (%)
Escherichia coli 1353 (65.6)
Klebsiella species 398 (19.3)
Proteus species 128 (6.2)
Pseudomonas aeruginosa 97 (4.7)
Staphylococcus aureus 72 (3.5)
Others 14 (0.7)
Total 2062 ( 100)
Abbreviations: % = percentage

Table 2: Age and sex distribution of Escherichia coli.

Age groups (years) Male Female Number of patients
0-9 12 17 29 (2.1%)
10-19 34 53 87 (6.4%)
20-29 52 243 295 (21.8%)
30-39 72 297 369 (27.3%)
40-49 12 169 181 (13.4%)
50-59 31 189 220 (16.3%)
60-69 19 74 93 (6.9%)
70-79 9 28 37 (2.7%)
80 -90 11 31 42 (3.1%)
Total 252 1101 1353(100%)
Abbreviations: % = percentage

Table 3: Yearly antimicrobial susceptibility pattern of E. coli.

Antibiotics 2013 – 2014 2014 – 2015 2015 – 2016 Statistical difference
  Sensitivity (%) Resistance (%) Sensitivity (%) Resistance (%) Sensitivity (%) Resistance (%) X² -stat df Sig
Ciprofloxacin 127 (32) 270 (68) 103 (24.2) 323 (75.8) 110 (20.8) 420 (79.2) 15.5 2 <0.001*
Augmentin 115 (29.0) 282 (71.0) 108 (25.4) 318 (74.6) 112 (21.1) 418 (78.9) 7.6 2 0.022*
Cotrimoxazole 138 (34.8) 259 (65.2) 104 (24.4) 322 (75.6) 104 (19.6) 426 (80.4) 27.8 2 <0.001*
Amoxicillin 122 (30.7) 275 (69.3) 116 (27.2) 310 (72.8) 100 (18.9) 430 (81.1) 18.7 2 <0.001*
Levofloxacin 185 (46.6) 212 (53.4) 206 (48.4) 220 (51.6) 253 (47.7) 277 (52.3) 0.26 2 0.878
Nitrofurantoin 297 (74.8) 100 (25.2) 288 (67.6) 138 (32.4) 417 (78.7) 113 (21.3) 15.2 2 <0.001*
Ceftriaxone 218 (54.9) 179 (45.1) 231 (54.2) 195 (45.8) 327 (61.7) 203 (38.3) 6.8 2 0.034*
Gentamicin 183 (46.1) 214 (53.9) 191 (44.8) 235 (55.2) 201 (37.9) 329 (62.1) 7.6 2 0.022*
Ofloxacin 127 (32.0) 270 (68.0) 129 (30.3) 297 (69.7) 132 (24.9) 398 (75.1) 6.4 2 0.042*
Imipenem 199 (50.2) 198 (49.8) 219 (51.4) 207 (48.6) 286 (54.0) 244 (46.0) 1.4 2 0.488
Meropenem 206 (51.9) 191 (48.1) 215 (50.5) 211 (49.5) 266 (50.2) 264 (49.8) 0.3 2 0.867
Cefotaxime 197 (49.6) 200 (50.4) 211 (49.5) 215 (50.5) 250 (47.2) 280 (52.8) 0.7 2 0.688
Key: % = percentage; *= statistical significant

Table 4: Multiple antibiotics resistance indices for E. coli.

No of resistant antibiotics Frequency MAR index Percentage (%)
3 17 0.25 1.3
4 24 0.333 1.8
5 36 0.417 2.7
6 97 0.500 7.2
7 129 0.583 9.5
8 179 0.667 13.2
9 299 0.750 22.1
10 394 0.833 29.2
11 178 0.917 13.2
Total 1353 5.25 100.0
Key: % = Percentage

 

CONCLUSION

There is increase in multiple drug resistant uropathogenic E .coli in this study. Hence, the need for urgent development of guideline for the effective treatment of UTIs in our hospital. Active Implementation of this guideline and practice of antibiotic stewardship will surely reduce the multi-drug resistance pattern in the coming years.

REFERENCES

1. Lüthje P, Brauner A. Novel strategies in the prevention and treatment of urinary tract infections. Pathogens. 2016; 5: 1-14.

2. Ani O, Odeta N, Onwe S. Burden of urinary tract infection among female students: South Eastern side of story. Int J Trop Dis Heal. 2016; 12: 1-7.

3. Lawani E, Alade T, Oyelaran D. Urinary tract infection amongst pregnant women in Amassoma, Southern Nigeria. Afr j Microbiol Res. 2015; 9: 355-359.

4. Ani OC, Onwe CS, Nnabugwu CC. Evaluation of female residents for urinary tract infections. Onicha local government Area, Ebonyi State, Nigeria. Niger J Parasitol. 2015; 36: 50-54.

5. Feld LG, Mattoo TK. Urinary Tract Infections and Vesicoureteral Reflux in F Infants and Children. Pediatr Rev. 2010; 31: 451-463.

6. Anozie BO, Lawani OL, Esike CO, Mamah E, Ajah L. Prevalence and common microbial isolates of urinary tract infection in pregnancy; A four year review in a tertiary health institution in Abakaliki, South East Nigeria. Am J Clin Res. 2016; 4: 25-28.

7. Ramanath KV, Shafiya SB. Prescription pattern of antibiotic usage for urinary tract infection treated in a rural tertiary care hospital. India J Pharmacy Pract. 2011; 4: 57-63.

8. Iregbu KC, Nwajiobi PI. Urinary tract infections in a tertiary hospital in Abuja, Nigeria. Afr J Clin Microbiol. 2013; 14: 169-173.

9. Dada-Adegbola HO, Muili KA. Antibiotic susceptibility pattern of urinary tract pathogens in Ibadan, Nigeria. Afr J Med Med Sci. 2010; 39: 173-179.

10. Akujobi CN, Ewuru CP. Detection of extended spectrum betalactamases in Gram negative bacilli from clinical specimens in a teaching hospital in South Eastern Nigeria. Niger Med J. 2010; 51: 141-146.

11. Sanches GV, Baird AM, Arlowsky JA, Master RN, Bordon JM. Nitrofurantoin retains antimicrobial activity against multidrug resistant urinary Escherichia coli from US outpatients. J Antimicrob Chemother. 2014; 49: 3259-3262.

12. Giwa FJ, Ige OT, Haruna DM, Yaqub Y, Lamido TZ, Usman SY. ExtendedSpectrum beta-lactamase production and antimicrobial susceptibility pattern of Uropathogens in a Tertiary Hospital in Northwestern Nigeria. Ann Trop Pathol. 2018; 9: 11-16.

13. Koneman E, Allen S, Janda W, Schreckenberger P. The Enterobacteriaceae In: 6th edn. Koneman’s color atlas and text book of diagnostic microbiology Philadelphia: PA Lippincott Williams & Wilkins. 2006; 624-662.

14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty fifth informational Supplement (M100-S25).

15. Krumperman PH. Multiple antibiotics resistant indexing of E. coli to identified high risk sources of fecal contamination of foods. Appl Enviro Microbiol. 1983; 46: 165-170.

16. Theodros G. Bacterial pathogens implicated in causing urinary tract infection and their antimicrobial susceptibility pattern in Ethiopia. Revista CENIC. Ciencias Biologicas. 2010; 41: 1-6.

17. Manikandan C, Amsath A. Prevalence and distribution of bacteria and fungi isolated from patients with urinary tract infections in pattukkottai, tamilnadu, India. Int J Pure Appl Zool. 2013; 1: 213-222.

18. Prakash D, Saxena RS. Distribution and antimicrobial susceptibility pattern of bacterial pathogens causing urinary tract infection in urban community of Meerut city, India. Microbiol. 2013; 2013: 749-629.

19. Akoachere JF, Yvonne S, Akum NH, Seraphine EN. Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns. BMC Res Notes. 2012; 5: 219.

20. Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016; 7: 22-26.

21. Bahadan J, Teo SS, Mathew S. Aetiology of community-acquired urinary tract infection and antimicrobial susceptibility patterns of uropathogens isolated. Singapore Med J. 2011; 52: 415-420.

22. Ochada NS, Nasiru IA, ThairuY, Okanlowan MB, Abdulakeem YO. Antimicrobial susceptibility pattern of urinary pathogens isolated from two tertiary hospitals in south western Nigeria. Afr J Clin Exp Microbiol. 2015; 16: 12-22.

23. Ehinmidu JO. Antibiotic susceptibility patterns of urine bacterial isolates in Zaria, Nigeria. Trp J Pharm Res. 2003; 2: 223-228.

24. Dash M, Padhi S, Mohanty I, Panda P, Parida B. Antimicrobial resistance in pathogens causing urinary tract infections in Rural Community of Odisha, India. J Family Community Med. 2013; 20: 20-26.

25. den Heijer CD, Penders J, Donker GA, Bruggeman CA Bruggeman CA, Stobberingh EE. The importance of gender stratified antibiotic resistance surveillance study. PLoS One. 2013; 8: e60497.

26. Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med. 2016; 7: 22-26.

27. Ihsan A, Safia A, Saji M Javid I. Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pacific J Trop Biomed. 2016; 6: 60-66.

28. Brett W. Diagnosis and Treatment of Urinary Tract Infections in Children. Am Fam Physician. 2011; 83: 409-416.

Martin O, Ifeyinwa N, Samuel E, Paul N, Ibuchukwu O, et al. (2018) Antibiotics Resistant Profile of Multi Drug Resistance Uropathogenic Escherichia coli in Southeastern Nigeria Ann Clin Med Microbiol 3(2): 1020.

Received : 04 Dec 2018
Accepted : 28 Dec 2018
Published : 31 Dec 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X